SerpinA3在眼眶成纤维细胞中参与Graves眼病发病机制的作用
研究比较了Graves眼病(GO)与正常者眼眶组织中SerpinA3的表达,并在体外培养的眼眶成纤维细胞中通过小干扰RNA沉默SerpinA3后观察炎症与脂肪分化指标。结果显示GO组织SerpinA3转录水平显著升高,沉默SerpinA3可抑制IL-1β诱导的炎症介质表达、脂肪分化及透明质酸产生。作者认为SerpinA3在GO中起重要作用,可能成为新的治疗靶点。
要点
- GO患者眼眶组织中SerpinA3转录水平显著高于正常对照。
- 沉默SerpinA3可抑制IL-1β诱导的多种炎症因子和信号通路磷酸化水平。
- 沉默SerpinA3减少透明质酸产生和脂肪分化,作者认为其可能为治疗靶点。
核心结论
- 沉默SerpinA3可减弱促炎介质表达、脂肪分化和透明质酸产生,结果提示SerpinA3在GO中起重要作用并可能成为新的治疗靶点。
研究设计与样本
- 研究比较了GO患者(n=30)与正常参与者(n=28)眼眶组织外植体中SerpinA3的表达,采用实时PCR检测。
- 对GO来源(n=3)与正常来源(n=3)的眼眶成纤维细胞,在IL-1β刺激前转染或不转染针对SerpinA3的小干扰RNA。
- 采用Western blotting评估炎症细胞因子和信号分子表达,油红O染色评估脂肪分化,Western blotting检测脂肪分化标志物。
- 采用酶联免疫吸附试验比较GO(n=4)与正常参与者(n=3)中前列腺素E2和透明质酸水平。
主要发现
- GO眼眶组织中SerpinA3转录水平显著高于正常组织。
- 沉默SerpinA3抑制了IL-1β诱导的IL-6、IL-8、单核细胞趋化蛋白1、细胞间黏附分子1、环氧合酶2和前列腺素E2的表达。
- 沉默SerpinA3降低了磷酸化核因子κB、Akt、细胞外信号调节激酶、p38和c-Jun N端激酶的水平。
- 沉默SerpinA3减少了透明质酸产生、脂肪分化及脂肪分化标志物表达,包括过氧化物酶体增殖物激活受体γ、CCAAT/增强子结合蛋白α和β、脂肪细胞蛋白2、脂联素和瘦素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We investigated the implications of SerpinA3, a secretory serine protease inhibitor, in inflammation and adipogenesis of Graves' orbitopathy (GO). To identify its precise function in GO pathogenesis, we evaluated the role of SerpinA3 in the inflammation and adipogenesis of GO. METHODS: SerpinA3 expression was compared between GO (n = 30) and normal participants (n = 28) in orbital tissue explants using real-time PCR. Orbital fibroblasts from GO (n = 3) and normal participants (n = 3) were transfected with or without small interfering RNA against SerpinA3 before IL-1β stimulation. Western blotting assessed inflammatory cytokine and signaling molecule expression. Adipogenic differentiation was assessed using Oil Red O staining, and adipogenic marker expression was determined through Western blotting. Enzyme-linked immunosorbent assay was used to compare prostaglandin E2 (PGE2) and hyaluronan levels in GO (n = 4) and normal participants (n = 3). RESULTS: SerpinA3 transcript levels were significantly higher in GO orbital tissues. Silencing SerpinA3 suppressed the IL-1β-induced expression of IL-6, IL-8, monocyte chemotactic protein 1, intercellular adhesion molecule 1, cyclooxygenase 2, and PGE2 and attenuated the levels of phosphorylated nuclear factor κB, Akt, extracellular signal-regulated kinase, p38, and c-Jun N-terminal kinase. Moreover, silencing SerpinA3 reduced hyaluronan production, adipogenic differentiation, and adipogenic marker expression, including peroxisome proliferator-activated receptor-γ, CCAAT/enhancer-binding proteins α and β, adipocyte protein 2, adiponectin, and leptin. CONCLUSIONS: Silencing SerpinA3 attenuated the expression of proinflammatory mediators, adipogenic differentiation, and hyaluronan production. Our results indicate that SerpinA3 plays a significant role in GO and may serve as a novel therapeutic target.
引用
- Kim MS, Choi SH, Park HY, et al. Role of SerpinA3 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts. Invest Ophthalmol Vis Sci. 2025. PMID: 40202736. doi:10.1167/iovs.66.4.20
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。